Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Chimeric 2'-O-(2-methoxyethyl) modified oligonucleotide targeted to huntingtin RNA

EU orphan designation number: EU/3/15/1453   
Active ingredient: Chimeric 2'-O-(2-methoxyethyl) modified oligonucleotide targeted to huntingtin RNA
Indication: Treatment of Huntington’s disease
Sponsor: Roche Registration GmbH
Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/03/2015 Orphan designation EMA/OD/256/14 (2015)2019 of 19/03/2015
7/04/2016 Change of name and/or address of sponsor
29/05/2018 Transfer of orphan designation EMA/OD/256/14/T/01 (2018)3401 of 25/02/2018